iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy.
| Revenue (TTM) | 523,030 |
| Gross Profit (TTM) | 327,350 |
| EBITDA | $-5.17M |
| Operating Margin | -682.00% |
| Return on Equity | -71.30% |
| Return on Assets | -41.00% |
| Revenue/Share (TTM) | $0.03 |
| Book Value | $0.36 |
| Price-to-Book | 0.98 |
| Price-to-Sales (TTM) | 16.66 |
| EV/Revenue | 6.18 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 91.60% |
| Shares Outstanding | $9.38M |
| Float | $7.45M |
| % Insiders | 21.21% |
| % Institutions | 2.79% |
Volatility is currently contracting